Calypso Medical Technologies, Inc.
CalypsoR Medical Technologies, Inc. is a medical device company developing innovative tools and therapies for the radiation oncology market. Their Calypso 4DR Localization System and BeaconR Transponder enable radiation therapists to localize a target organ and track organ motion continuously and in real-time during radiation therapy.
| Company | Calypso Medical Technologies, Inc. |
|---|---|
| URL | http://calypsomedical.com/ |
Emory's Winship Cancer Institute announced today that it is the first cancer facility in Georgia to provide prostate cancer patients with "GPS for the body" in order to provide more precise radiation therap...
Calypso(R) Medical Reports Leading Cancer Centers Standardize Their Prostate Cancer Therapy on GPS for the Body(R)
Los Angeles, CA - October 28, 2007 - Calypso Medical is announcing results of scientific investigations with the CalypsoR 4D Localization System? to be presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) 49th An...
Seattle, WA and Sunnyvale, CA, - October 28, 2007 - Calypso Medical and IMPAC Medical Systems, an Elekta company, have identified product collaboration projects which will further enable integration of oncology management systems with the Calypso
CalypsoR Medical Technologies, Inc., Investigators Present Progress at AAPM 49th Annual Meeting
Patients will benefit from early adoption of technology from Seattle-based Calypso Medical
Calypso(R) Medical Technologies, Inc., $42.2M Private Equity Financing Provides Expansion Capital
Seattle, WA - January 5, 2007 - Today, CalypsoR Medical Technologies, Inc., announced closure of its Series D private equity financing, totaling $42.2 million. Apothecary Capital, LLC (Chicago, IL), Glenview Capital Management (New York, ...
Philadelphia, PA - November 5, 2006 - CalypsoR Medical announces its intention to collaborate on future product offerings with IMPAC Medical Systems, Inc. (IMPAC), an Elekta company.
Philadelphia, PA - November 5, 2006 - CalypsoR Medical announces product development advancement on strategic collaboration efforts with Philips at the 48th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, N...
CalypsoR Medical Technologies, Inc. Investigators Present Real-Time Prostate Motion Data at ASTRO's 48th Annual Meeting
Calypso(R) Medical Receives FDA 510(k) Clearance for the Calypso(R) 4D Localization System
First continuous, real-time method to locate and ontinuously track tumor motion during cancer treatment
CalypsoR Medical Technologies, Inc. Investigators Present Progress at ASTRO's 47th Annual Meeting
CalypsoR Medical Technologies, Inc., Investigators Present Progress at AAPM 47th Annual Meeting
Seattle, WA - July 19, 2005 - CalypsoR Medical Technologies, Inc. today announced that it has begun clinical studies for patients with prostate cancer receiving external beam radiation therapy. The study will evaluate the usability and sa...
06/17/2008 | Taro InabaBoehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
11/01/2007 | Nobuhiro Shimizu【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
07/18/2007 | Taro InabaMitsui Ventures Launching a New Approach to Seed Financing